These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Science to practice: will contrast agents for molecular imaging of angiogenesis help overcome the limitations of functional vascular imaging? Kiessling F Radiology; 2013 Aug; 268(2):309-11. PubMed ID: 23882090 [TBL] [Abstract][Full Text] [Related]
4. Preclinical MRI experience in imaging angiogenesis. Neeman M Cancer Metastasis Rev; 2000; 19(1-2):39-43. PubMed ID: 11191061 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of contrast agents targeted to the tumor vasculature in molecular magnetic resonance imaging. Oostendorp M; Douma K; Hackeng TM; van Zandvoort MA; Post MJ; Backes WH Contrast Media Mol Imaging; 2010; 5(1):9-17. PubMed ID: 20101742 [TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance susceptibility based perfusion imaging of tumors using iron oxide nanoparticles. Pathak AP Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(1):84-97. PubMed ID: 20049781 [TBL] [Abstract][Full Text] [Related]
8. An introduction to functional and molecular imaging with MRI. Gallagher FA Clin Radiol; 2010 Jul; 65(7):557-66. PubMed ID: 20541655 [TBL] [Abstract][Full Text] [Related]
9. Special techniques for imaging blood flow to tumors. Choyke PL; Knopp MV; Libutti SK Cancer J; 2002; 8(2):109-18. PubMed ID: 11999945 [TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging. Bhujwalla ZM; Artemov D; Glockner J Top Magn Reson Imaging; 1999 Apr; 10(2):92-103. PubMed ID: 10551624 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging. Kiessling F; Jugold M; Woenne EC; Brix G Eur Radiol; 2007 Aug; 17(8):2136-48. PubMed ID: 17308924 [TBL] [Abstract][Full Text] [Related]